GPX4 and neoplasm: Specifically, D-2- hydroxyglutaric acid, a metabolite produced by mutant IDH1 in tumor cells, reduces the expression of antioxidant GPX4 in tumor cells, thus enhancing the ferroptosis sensitivity induced by Erastin (Wang et al., 2019).